Expression of 11Β-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome

International Journal of Obesity

Volumn 33, Issue 11, 2009, Pages 1249-1256

  Svendsen, P F ^a   Madsbad, S ^a   Nilas, L ^a   Paulsen, S K ^b   Pedersen, S B ^b  

^a Mental Health Services CPH   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

11 HSD; PCOS

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ADIPONECTIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LEPTIN; MESSENGER RNA;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; ANALYSIS OF VARIANCE; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ENZYMOLOGY; INSULIN RESISTANCE; METABOLISM; PHOTON ABSORPTIOMETRY; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ABSORPTIOMETRY, PHOTON; ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; SUBCUTANEOUS FAT; THINNESS;

EID: 70450250097     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.165     Document Type: Article

References (46)

1. Friedman TC, Mastorakos G, Newman TD, Mullen NM, Horton EG, Costello R et al. Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J 1996; 43: 645-655.
2. Krakoff LR. Glucocorticoid excess syndromes causing hypertension. Cardiol Clin 1988; 6: 537-545.
3. Nosadini R, Del PS, Tiengo A, Valerio A, Muggeo M, Opocher G et al. Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab 1983; 57: 529-536.
4. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999; 84: 1022-1027.
5. Andrews RC, Herlihy O, Livingstone DE, Andrew R, Walker BR. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab 2002; 87: 5587-5593.
6. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydro-xysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002; 87: 3330-3336.
7. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170.
8. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxyster-oid dehydrogenase type 1 null mice. J Biol Chem 2001; 276: 41293-41300.
9. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418-1421.
10. Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DE, Permana PA et al. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogen-ase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab 2003; 88: 2738-2744.
11. Kannisto K, Pietilainen KH, Ehrenborg E, Rissanen A, Kaprio J, Hamsten A et al. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J Clin Endocrinol Metab 2004; 89: 4414-4421.
12. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CR. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorti-coid receptor activation. J Clin Endocrinol Metab 1995; 80: 3155-3159.
13. Bublitz C, Steavenson S. The pentose phosphate pathway in the endoplasmic reticulum. J Biol Chem 1988; 263: 12849-12853.
14. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE et al. Hexose-6-phosphate dehydrogenase confers. oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogen-ase type 1. J Mol Endocrinol 2005; 34: 675-684.
15. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS et al. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988; 2: 986-989.
16. Milagro FI, Campion J, Martinez JA. 11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity. J Steroid Biochem Mol Biol 2007; 104: 81-84.
17. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488
18. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus worshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.
19. Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R et al. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 2295-2302.
20. Low SC, Assaad SN, Rajan V, Chapman KE, Edwards CR, Seckl JR. Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J Endocrinol 1993; 139: 27-35.
21. Paulsen SK, Pedersen SB, Fisker S, Richelsen B. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 2007; 15: 1954-1960.
22. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447.
23. Svendsen PF, Nilas L, Norgaard K, Jensen JE, Madsbad S. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod 2008; 23: 2113-2121.
24. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672.
25. Stewart PM, Shackleton CH, Beastall GH, Edwards CR. 5 alpha-reductase activity in polycystic ovary syndrome. Lancet 1990; 335: 431-433.
26. Tsilchorozidou T, Honour JW, Conway GS. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates. J Clin Endocrinol Metab 2003; 88: 5907-5913.
27. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 2760-2766.
28. Chin D, Shackleton C, Prasad VK, Kohn B, David R, Imperato-McGinley J et al. Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Pediatr Endocrinol Metab 2000; 13: 253-259.
29. Gallagher TF, Kappas A, Hellman L, Lipsett MB, Pearson OH, West CD. Adrenocortical hyperfunction in idiopathic hirsutism and the Stein-Leventhal syndrome. J Clin Invest 1958; 37: 794-799.
30. Wild RA, Umstot ES, Andersen RN, Ranney GB, Givens JR. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandro-genism. Am J Obstet Gynecol 1983; 146: 602-606.
31. Hoffman DI, Klove K, Lobo RA. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 1984; 42: 76-81.
32. Steinberger E, Smith KD, Rodriguez-Rigau LJ. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women. J Clin Endocrinol Metab 1984; 59: 471-477.
33. Carmina E, Rosato F, Janni A. Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients. J Endocrinol Invest 1986; 9: 5-9.
34. Corton M, Botella-Carretero JI, Benguria A, Villuendas G, Zaballos A, San Millan JL et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 328-337.
35. San Millan JL, Botella-Carretero JI, Alvarez-Blasco F, Luque-Ramirez M, Sancho J, Moghetti P et al. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydro-genase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 4157-4162.
36. White PC. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample. J Clin Endocrinol Metab 2005; 90: 5880-5883.
37. Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T, Walker BR. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 2003; 88: 3983-3988.
38. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004; 12: 9-17.
39. Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, Morton NM et al. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf) 2006; 65: 81-87.
40. Low SC, Chapman KE, Edwards CR, Wells T, Robinson IC, Seckl JR. Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehy-drogenase in the rat: the role of growth hormone patterns. J Endocrinol 1994; 143: 541-548.
41. Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydro-genase type 1. J Endocrinol 1999; 160: 103-109.
42. Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 1998; 83: 1806-1809.
43. Raven PW, Taylor NF. Sex differences in the human metabolism of cortisol. Endocr Res 1996; 22: 751-755.
44. Weaver JU, Taylor NF, Monson JP, Wood PJ, Kelly WF. Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clin Endocrinol (Oxf) 1998; 49: 13-20.
45. Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity (Silver Spring) 2008; 16: 731-735.
46. Barat P, Livingstone DE, Elferink CM, McDonnell CR, Walker BR, Andrew R. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats. Endocrinology 2007; 148: 4836-4843